TITLE

Omeprazole and Clopidogrel -- Is There a Clinically Meaningful Interaction?

AUTHOR(S)
Boyle, Andrew J.
PUB. DATE
January 2011
SOURCE
Clinical Cardiology Alert;Jan2011, Vol. 30 Issue 1, p4
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
57748974

 

Related Articles

  • Omeprazole and Clopidogrel -- Is There a Clinically Meaningful Interaction? Boyle, Andrew J. // Clinical Oncology Alert;Jan2011, Vol. 27 Issue 1, p4 

    The article highlights a placebo-controlled trial by Bhatt and colleagues to determine a clinical interaction between Omeprazole that reduces the risk of Gastrointestinal (GI) bleeding in patients on dual anti-platelet therapy (DAPT) and Clopidogrel. It is inferred that there was no apparent...

  • Proton Pump Inhibitors and the Prevention of Recurrent GI Bleed in Patients Treated with Clopidogrel. Oyetayo, O.O.; Farris, C.A.; Wahawisan, J. // Clinical Medicine Insights: Therapeutics;2012, Issue 4, p9 

    Clopidogrel is an antiplatelet agent indicated in the management of atherothrombotic conditions. Bleeding is a predictable adverse event associated with antiplatelet agents. While non-ulcerogenic; a major site of bleeding with clopidogrel is the gastrointestinal (GI) tract. The risk of GI...

  • Addition of omeprazole to dual antiplatelet therapy with clopidogrel plus aspirin lowers the risk of upper gastrointestinal bleeding. Siller-Matula, Jolanta M.; Delle-Karth, Georg // Evidence Based Medicine;Oct2011, Vol. 16 Issue 5, p144 

    The article presents a commentary on the study "Clopidogrel with or without omeprazole in coronary artery disease," published in a 2010 issue of the "New England Journal of Medicine." It notes a discrepancy between trial results and observational data on the risk of cardiovascular events...

  • Clopidogrel Plus Aspirin After Transient Ischemic Attack. Boyle, Andrew J. // Clinical Cardiology Alert;Aug2013, Vol. 32 Issue 8, p57 

    The article discusses the use of clopidogrel and aspirin that reduce the early risk of transient ischemic attacks (TIAs) and recurrent minor strokes. It notes that clopidogrel in addition to aspirin have not been tested in TIA and minor stroke patients but are at lower risk of intracerebral...

  • Secondary Prevention of Lacunar Stroke.  // Clinical Cardiology Alert;Nov2012 Clinical Briefs In Primary Care, p21 

    The article discusses the Secondary Prevention of Small Subcortical Strokes (SPS3) trial, which showed that Aspirin (ASA)+ clopidogrel (CLOP)was not as effective as ASA monotherapy in preventing lacunar strokes (L-CVA).

  • Secondary Prevention of Lacunar Stroke.  // Critical Care Alert;Nov2012 Clinical Briefs in Primary Care, p21 

    The article reports on the Secondary Prevention of Small Subcortical Strokes (SPS3) trial which finds that aspirin (ASA) along with clopidogrel (CLOP) is not more effective than ASA alone for prevention of lacunar stroke (L-CVA), and is also linked with greater bleeding risk and all-cause mortality.

  • Secondary Prevention of Lacunar Stroke. Kuritzky, Louis // Clinical Oncology Alert;Nov2012 Clinical Briefs In Primary Care, p21 

    The article discusses the Secondary Prevention of Small Subcortical Strokes (SPS3) trial, which showed that Aspirin (ASA)+ clopidogrel (CLOP)was not as effective as ASA monotherapy in preventing lacunar strokes (L-CVA).

  • ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use Abraham, Neena S; Hlatky, Mark A; Antman, Elliott M; Bhatt, Deepak L; Bjorkman, David J; Clark, Craig B; Furberg, Curt D; Johnson, David A; Kahi, Charles J; Laine, Loren; Mahaffey, Kenneth W; Quigley, Eamonn M; Scheiman, James; Sperling, Laurence S; Tomaselli, Gordon F // American Journal of Gastroenterology;Dec2010, Vol. 105 Issue 12, p2533 

    The article discusses the use of proton pump inhibitors (PPI) and thienopyridines as an alternative treatment for cardiovascular (CV) diseases. It says that clopidogrel is more effective than aspirin in reducing main CV events. It mentions the greater risk for gastrointestinal (GI) bleeding in...

  • Lansoprazole provided more effective and faster relief for heartburn than did omeprazole in erosive esophagitis. Hoogerwerf, W. A.; Pasricha, P. Jay // ACP Journal Club;May/Jun2002, Vol. 136 Issue 3, p95 

    Comments on a study which compared lansoprazole and omeprazole in onset of heartburn relief in erosive esophagitis patients. Outcome measures; Effectiveness of lansoprazole and omeprazole in eliminating heartburn on patients with erosive esophagitis; Significance of proton-pump inhibitors to...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics